Nevro Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Good day, everyone, this is David Lewis, Medical Device Analyst at Morgan Stanley. Thanks for joining us here as we progress into the afternoon on day 1 of the Morgan Stanley Healthcare Conference 2020. It's my pleasure to have with us here Nevro and both their President and CEO; and Rod MacLeod, their CFO, this morning.
I think Keith's going to dispense with any preamble, we're going to jump right into Q&A. As I always mentioned that before I start, please go to the Morgan Stanley research disclosure website and see my research disclosures and other fun facts about me.
Questions & Answers
But look, we always appreciate, Keith, when a company comes to our conference, it comes out with new -- fresh news announcements, so we'll start there. So manufacturing, I mean, this has been a -- since the IPO of Nevro, this is a question I've asked the prior CFO every single year. When do you take more control of your long-term
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
